Confidential opportunity to acquire an established, multi-location integrative
and functional medicine practice serving an affluent Mid-Atlantic metropolitan
market. The practice has operated for approximately two decades and has
developed a recognized regional reputation for personalized, physician-led care
delivered through a 100% direct-pay model. The business does not bill commercial
insurance, Medicare, or Medicaid, eliminating payer-mix exposure, reimbursement
delays, coding disputes, and collection risk associated with traditional medical
practices.
The practice provides a broad range of recurring wellness and specialty-care
programs, including hormone optimization, medical weight management, longevity
and regenerative medicine, peptide protocols, intravenous therapies,
chronic-condition support, cardiovascular risk reduction, sexual wellness,
advanced laboratory evaluation, nutritional products, and personalized treatment
planning. Patients begin with a comprehensive assessment and laboratory workup
before enrolling in an appropriate annual program. Programs may be paid in a
single installment or through structured payment arrangements, creating
predictable revenue and strong patient continuity.
The business serves hundreds of active program participants, with most enrolled
under twelve-month agreements and a high historical renewal rate. A meaningful
portion of annual revenue is generated from renewals, providing an attractive
base of recurring business before new-patient acquisition. Revenue is
diversified across memberships, clinical services, therapies, medications,
laboratory testing, diagnostics, supplements, and related products.
No
individual patient, program, provider, or referral source represents a material
concentration of revenue.
The practice operates from several professionally appointed leased clinics and
requires no owned real estate. Its asset-light structure includes office
furniture, computer equipment, exam tables, specialized medical equipment,
secure access systems, and other assets necessary to continue operations.
The
locations are supported by established third-party laboratory, pharmacy, and
medical-supply relationships. The practice does not own or operate a laboratory
or compounding pharmacy.
Clinical services are delivered by an experienced multi-provider team that
includes physicians, an advanced-practice provider, nurses, and patient-care
coordinators.
A full-time general manager oversees business operations, sales,
and administrative execution, reducing the founder's involvement in nonclinical
activities. Key personnel are expected to support an orderly ownership
transition. The lead physician is willing to remain on a reduced clinical
schedule for an extended transition period, while existing management can
provide operational continuity.
The practice uses an integrated electronic health record, patient portal,
scheduling, enrollment, payment, and practice-management platform. New patients
complete intake materials electronically, including health history, consent
documentation, and payment information. The direct-pay model allows payment to
be collected at enrollment or according to an approved installment schedule.
Major credit cards and healthcare spending accounts are accepted, improving
accessibility while maintaining favorable cash-conversion characteristics.
Annual revenue has remained near $2.9 million despite inconsistent marketing
performance, regional economic softness, provider-recruiting challenges, and
underperformance at a newer location.
The current full-year pro forma projects
approximately $2.9 million in revenue and approximately $383,000 in adjusted
EBITDA after including market-rate replacement clinical compensation. A
physician buyer assuming the lead clinical role may realize substantially
greater owner-operator cash flow.